Abstract Oral fluid (OF) is an alternative biological matrix for monitoring cannabis intake in drug testing, and drugged driving (DUID) programs, but OF cannabinoid test interpretation is challenging. Controlled cannabinoid administration studies provide a scientific database for interpreting cannabinoid OF tests. We compared differences in OF cannabinoid concentrations from 19 h before to 30 h after smoking a 6.8 % THC cigarette in chronic frequent and occasional cannabis smokers. OF was collected with the Statsure Saliva Sampler™ OF device. 2D-GC-MS was used to quantify cannabinoids in 357 OF specimens; 65 had inadequate OF volume within 3 h after smoking. All OF specimens were THC-positive for up to 13.5 h after smoking, without significant differences between frequent and occasional smokers over 30 h. Cannabidiol (CBD) and cannabinol (CBN) had short median last detection times (2.5-4 h for CBD and 6-8 h for CBN) in both groups. THCCOOH was detected in 25 and 212 occasional and frequent smokers' OF samples, respectively. THCCOOH provided longer detection windows than THC in all frequent smokers. As THCCOOH is not present in cannabis smoke, its presence in OF minimizes the potential for false positive results from passive environmental smoke exposure, and can identify oral THC ingestion, while OF THC cannot. THC≥1 μg/L, in addition to CBD≥1 μg/L or CBN≥1 μg/L suggested recent cannabis intake (≤13.5 h), important for DUID cases, whereas THC≥1 μg/L or THC≥2 μg/L cutoffs had longer detection windows (≥30 h), important for workplace testing. THCCOOH windows of detection for chronic, frequent cannabis smokers extended beyond 30 h, while they were shorter (0-24 h) for occasional cannabis smokers.
Introduction
Cannabis, also known as marijuana or hashish, is the most widely consumed drug in the world, with a prevalence between 2.6 and 5 % in 2010 [1] . In the USA in 2011, 18.1 million people smoked cannabis in the last past month [2] . Cannabis also was the most common illicit drug found in drivers, according the 2007 National Roadside Survey of Alcohol and Drug Use by Drivers [3, 4] .
Saliva or oral fluid (OF) is now extensively utilized in many different drug testing programs [5] including pain management [6] , workplace [7] , and driving under influence of drugs (DUID) testing [8] . The main advantages of OF are the simplicity and noninvasiveness of samples collected under observation making adulteration more difficult [9] .
Determining OF cannabinoid pharmacokinetics after controlled cannabinoid administration is important to determine drug detection windows, establish markers that can distinguish cannabis intake from environmental smoke contamination, and identify new markers to improve OF interpretation. However, ideal drug detection windows are different depending on the purpose of monitoring. For workplace drug testing, detection windows should be as long as possible due to widely separated specimen collections, while shorter detection windows identifying recent use may be needed for human performance testing in forensic, road safety or antidoping fields.
Passive environmental contamination from cannabis-laden smoke is another problem to consider when interpreting OF drug testing results. Environmental cannabis smoke exposure produced positive peak OF Tetrahydrocannabinol (THC) concentrations (up to 1.2 μg/L) in four non-smokers present in a van with four individuals smoking a 10.4 % THC cigarette 1.5 h after cessation of smoking, when OF was collected outside the van with the Intercept oral fluid device [10] . More recently, Moore et al. showed that up to 17 μg/L THC and cannabinol (CBN) were quantified in OF after 3 h environmental smoke exposure in Dutch coffee shops, but 11-nor-9-carboxy-tetrahydrocannabinol (THCCOOH) was not found in cannabis smoke, making this analyte a good marker for differentiating acute passive environmental exposure from cannabis smoking [11] .
In order to provide a scientific database for interpreting cannabinoid OF tests, we conducted controlled oral [12] [13] [14] [15] , submucosal [12] , and smoked cannabinoid administration studies [16, 17] , and cannabinoid excretion studies during sustained abstinence [18] . However, many participants were chronic, frequent smokers and all studies utilized expectorated OF and/or OF collected with the Quantisal™ device.
Smoking topography (i.e., duration and depth of inhalation and exhalation, hold time in the lungs, and time between puffs) is affected by drug use frequency and chronicity, and potential tolerance development that influences THC plasma concentrations, and probably also oral cavity contamination [19] [20] [21] . Furthermore, chronic, frequent use of cannabis leads to accumulation of highly lipophilic THC in tissues, producing a gradual prolonged excretion of THC, and of its metabolite THCCOOH into blood [22] [23] [24] . Moreover, OF and plasma THCCOOH concentrations are correlated [25] ; consequently, differences in OF THCCOOH concentrations in chronic, frequent and occasional cannabis smokers may be observed, as is seen in plasma.
Toennes et al. compared THC OF pharmacokinetics over 8 h in occasional and chronic cannabis smokers following smoking of 500 μg/kg THC [26] . OF was collected with the Intercept DOA Oral Specimen Collection Device. No significant differences were observed between these two groups over this short time frame except for maximum THC concentration (C max ).
In the present study, OF was collected with the Statsure Saliva Sampler™ device utilized in the Driving Under the Influence of Drugs, Alcohol and Medicines (DRUID) European Union project. We quantified THC, 11-hydroxytetrahydrocannabinol (11-OH-THC), THCCOOH, cannabidiol (CBD), and CBN OF concentrations prior to and up to 30 h after ad libitum smoking of a single 6.8 % cannabis cigarette in chronic, frequent and occasional cannabis smokers. Comparison of OF cannabinoid disposition in these two cannabis smoker populations, analyte detection windows and potential cutoffs for different drug testing programs were evaluated to provide a scientific database to assess individual OF cannabinoid results.
Experimental

Study design
This clinical study, approved by the National Institute on Drug Abuse Institutional Review Board, recruited chronic frequent cannabis smokers (n =14) who smoked at least four times per week over the last year, and occasional smokers (n =10) who smoked less than twice a week. All participants were between 18 and 45 years old and provided written informed consent. Additional inclusion criteria included: systolic blood pressure ≤140 mmHg, diastolic blood pressure ≤90 mmHg, heart rate ≤100 bpm, an electrocardiogram 3-min rhythm strip without clinically relevant abnormalities, and peripheral veins suitable for venipuncture. Exclusion criteria included history or presence of any clinically significant illness, adverse event associated with cannabis intoxication, donation of more than 450 mL blood within 30 days, interest or participation in drug abuse treatment within 60 days, and for women, pregnancy or nursing. The study consisted of a 3-day, 2-night stay in a closed clinical research unit. Baseline measures and biological samples were collected before drug administration. Participants smoked ad libitum (10 min maximum) one 6.8±0.2 % (54 mg) THC, 0.25±0.08 CBD, and 0.21±0.02 % CBN cannabis cigarette the morning of Day 2 and provided OF up to 30 h after smoking.
Biological sample collection and analysis
The Statsure Saliva Sampler TM device (StatSure Diagnostic Systems), utilized for OF collection has an absorptive cellulose pad, a volume adequacy indicator that turns blue upon collection of 1.0 mL OF, and a polypropylene tube containing 1mL elution/ stabilizing buffer, yielding a 1:1 OF dilution. OF was collected 19 and 1 h before and 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 10.5, 13.5, 21, 24, 26, 28, 30 h after smoking. All samples were stored at 4°C and analyzed within 24 h of collection. No weight correction was applied and, in the case of low OF volume, specimens were analyzed, and as we discuss, these concentrations were likely underestimated due to a greater dilution with elution buffer. THC, 11-OH-THC, THCCOOH, CBN, and CBD were quantified by two-dimensional gas chromatography mass spectrometry (2D-GC-MS) according to a previously published method [27] with minor modifications: calibrators and quality controls were prepared in 0.25 mL blank OF and 0.25 mL StatSure buffer to account for OF dilution. Also, GC column configuration for neutral cannabinoid analysis was changed to that of our plasma method [28] so that GC instruments could flexibly be utilized for either analysis; instruments were equipped with DB-1MS (Agilent Technologies) as the primary column and ZB-50 (Phenomenex) as the secondary column limits of quantification (LOQ) were 0.5 μg/L for THC, 11-OH-THC, CBD, and CBN, and 15 ng/L for THCCOOH. Upper LOQs were 50 μg/L for THC, 11-OH-THC, CBD, and CBN, and 500 ng/ L for THCCOOH. The modified method's performance was comparable to that of the original method with 1-2.7 %RSD intra-assay imprecision (n =6), 2.2-7.6 %RSD inter-assay imprecision (n =10). OF specimens were diluted with drug free OF-Statsure buffer mixture if analyte concentrations exceeded the upper LOQ.
Data analysis
Data were processed with Chemstation Data Analysis software (Agilent Technologies, Wilmington, DE, USA) to generate analyte concentrations. Quantification was carried out by linear regression with 1/x weighting. Low, medium and high concentration quality controls across the dynamic range of the assay were incorporated to ensure analytical quality throughout the run. IBM SPSS Statistics version 18.0 for Windows and Microsoft Excel were employed in statistical evaluations. Group medians were compared with the non-parametric Mann-Whitney U test, p value<0.05 indicated no significant difference between groups. When comparing median group concentrations at each time point (n =17), Bonferroni correction reduced type 1 errors; consequently, p <0.003 indicated significant difference between daily and occasional smokers. Areas under the curve (AUC) were estimated with Excel by the trapezoid method. For figures, values below the LOQ were considered as one tenth the LOQ.
Results
Fourteen chronic, frequent and 10 occasional cannabis smokers spent the night before smoking on the clinical unit to ensure that participants were not intoxicated at the time of smoking. OF specimens (N =382) were collected prior to and up to 30 h after cannabis smoking. Within 3 h after smoking, 54 or 56 % of specimens collected in this time frame had inadequate volume due to reduced salivation or "dry mouth." Low OF volume was noted in 22 of 24 specimens at 0.5 h, 18 at 1 h, 11 at 2 h and 3 at 3 h after smoking. Overall, 19 % (chronic frequent smokers) and 17 % (occasional smokers) of all OF specimens had an inadequate volume. There were no significant differences in the percentage of low-volume specimens or the length of time lowvolume specimens were obtained between groups. Table 1 presents demographics and self-reported cannabis smoking history for 24 participants. Median (range) age of first cannabis smoking, lifetime years of smoking, and body mass index (BMI) were 14 (11-25)years, 10.5 (4.4-17.6)years, and 26.1 (19.4-35.4) for the chronic frequent smokers and 16 (13) (14) (15) (16) (17) (18) (19) years, 17.7 (7.7-25.3)years and 24.7 (21-47.8) for occasional users. No significant differences were observed between chronic, frequent and occasional smokers for these parameters (p =0.522 for age of first use, and p =0.738 for body mass index) except for the lifetime smoking (p =0.038). A major difference between these groups was, as expected, the median number of joints smoked per week. Chronic, frequent smokers reported a median (range) of 28 joints per week (21-147), while occasional smokers reported 0.75 joints per week (0.06-2.5). Consequently, the number of days since last cannabis smoking also was different among groups, as almost every chronic frequent smoker reported intake the day prior to smoking (day of admission), whereas the last time for occasional smokers varied between 3 to 87 days. Two participants (M and N) were originally classified as occasional users by their self-report, but following analysis of biological specimens, reclassified as chronic, frequent smokers based on our previous findings [16, 29] . Figure 1 shows the median time course of THC, THCCOOH, CBD and CBN, while Table 2 describes the percentage of positive OF specimens (≥LOQ) for each of these analytes in the two groups. Data for 11-OH-THC are not included in the figures or tables because 98 % of OF specimens were negative. 11-OH-THC was only present in 10 specimens at the method's LOQ of 0.5 μg/L, with concentrations ranging between 0.6-2.6 μg/L. At admission, 19 h before controlled smoked cannabis, all OF specimens from occasional smokers were negative for all analytes. In chronic frequent smokers, 13 and 14 OF specimens were positive for THC and THCCOOH, with concentrations between 6-396 μg/L and 23-407 ng/L, respectively. Interestingly, 43 and 64 % of OF specimens were positive for CBD (0.6-7.9 μg/L) and CBN (0.9-16.1 μg/L). One hour prior to cannabis smoking, concentrations in frequent smokers' OF had decreased; no specimens were positive for CBD or CBN, and 11 were still positive for THC (0.9-7 μg/L). THCCOOH OF concentrations decreased 35 % from 19 to 1 h prior to smoking, but 100 % remained positive (20-223 ng/L) 1 h before controlled smoking began.
After smoking, OF THC concentrations increased rapidly in both groups with median C max concentrations 0.5 h post smoking (first collection time point) of 517 (189-6508)μg/L for chronic, frequent and 524 (85-1,471)μg/L for occasional cannabis smokers, although many of these were low-volume collections suggesting underestimated concentrations. Two occasional smokers had THC t max at 1 and 2 h after smoking, corresponding to C max of 561 μg/L and 1080 μg/L, respectively. This could be explained by low OF volumes in specimens collected 0.5 h after smoking for these two participants that would have generated a greater than 1:1 dilution with the buffer. Generally, THC OF concentrations progressively decreased and median concentrations fell from 218 (28.4-2,354)μg/L 1 h after smoking to 71.1 (7.5-350)μg/L after 2 h in chronic, frequent smokers as compared to 93.6 (48.4-561)μg/L to 78.3 (23.4-1,080)μg/L within the same interval in occasional smokers; 13.5 h after smoking, 100 % of 24 OF specimens were still THC-positive with median OF concentrations of 2.8 (0.8-18.4) for frequent and 1.8 (0.8-34.5)μg/L for occasional cannabis smokers. Median THC last detection times for frequent and occasional smokers were >30 (13.5→30) and 27 (21→30)h, respectively, documenting no significant differences (p =0.067) up to 30 h. There also were no significant differences between median areas under the curve (AUC 0→30h ) (Table 3) , 550 (176.9-4179) and 556 (139-1674)μg/L h for frequent and occasional smokers (p =0.539), revealing similar time courses as seen in Fig. 1 .
CBD and CBN had similar time courses to THC's, but with lower concentrations. CBD and CBN C max also occurred at 0.5 h for all participants except for the two participants with late THC C max . For these participants, C max occurred, as for THC, at 1 and 2 h. After 0.5 h, median CBD and CBN OF concentrations were 25 (4.5-254.5) and 36 (7-476)μg/L for frequent cannabis 5  100  100  100  100  100  100  100  20  1  100  100  100  100  100  100  100  10  2  100  100  79  100  100  100  100  40  3  100  100  50  40  93  80  100  10  4  100  100  50  20  86  70  100  20  5  100  100  50  20  86  80  100  50  6  100  100  29  20  64  60  100  20  8  100  100  7  0  50  40  100  20  10.5  100  100  14  0  29  10  100  10  13.5  100  100  0  0  29  30  100  40  21  93  90  0  0  0  0  93  0  24  86  60  0  0  0  0  93  10  26  79  40  0  0  0  0  100  0  28  64  50  0  0  7  0  71  0  30  64 AUC 0→30h for CBD (p =0.497) and CBN (p =0.771) showed no significant differences between frequent and occasional smokers. THCCOOH concentrations had the largest differences between the two smoking groups. 97 % of all frequent smokers' OF specimens were positive, while only 15 % of occasional smokers' specimens were positive. For frequent smokers, median THCCOOH C max was 126 (59.7-430)ng/L with an associated t max of 1 (0.5-10.5)h. Although a small decrease in THCCOOH concentrations was observed over time, 85 % of OF specimens remained positive 30 h after smoking at a median concentration of 25.5 (<LOQ-197)ng/L. For occasional smokers 5 h after cannabis intake, THCCOOH median was 17.6 (<LOQ-38.3)ng/L; however, overall, few specimens were positive and median THCCOOH concentration was 0 ng/L at all other time points. Furthermore, specimens were randomly positive and one or more negative specimens were found between two positive specimens.
The Substance Abuse and Mental Health Services Administration (SAMHSA) proposed a 2 μg/L THC confirmation cutoff; all participants' OF specimens were positive for 6 h. However, at 21 h after smoking, only 71 % of frequent smokers and 10 % of occasional smokers' specimens were positive. At the 1 μg/L cutoff utilized by the DRUID program, all participants were positive for 10.5 h. At 26 h, seven frequent smokers were positive; only 1 occasional smoker had THC concentrations >1 μg/L. In addition to DRUID and SAMHSA cutoffs, THCCOOH≥20 ng/L alone or in combination with THC≥1 and THC≥2 μg/L were evaluated. Combinations of THC≥ 1 μg/L+CBD ≥1 μg/L or CBN ≥1 μg/L also were investigated (Fig. 2) .
With a THCCOOH≥20 ng/L cutoff, 64 % of frequent smokers' specimens were still positive at 30 h. When cutoffs of THCCOOH≥20 ng/L and THC≥1 μg/L were applied, the number of positives for frequent smokers decreased linearly after 10.5 h, with one specimen positive at 30 h, greatly reducing the window of detection. When in combination with THC≥2 μg/L, the number of positive specimens started to decrease at 6 h, and 1 specimen remained positive at the last collection (30 h). For occasional smokers, 90 % of all collected OF were negative with a THCCOOH≥20 ng/L cutoff. With a THCCOOH cutoff ≥20 ng/L or THC≥2 μg/L considered by SAMSHA, 69 % of chronic frequent smokers were still positive at 30 h after smoking, while last detection time for occasional smokers was 24 h with 30 % positive. With THC≥1 μg/L and CBD≥1 μg/L cutoff, windows of detection were short for both groups; 3 h after smoking, only six participants (five frequent and one occasional smokers) remained positive. Using a THC≥1 μg/L and CBN≥1 μg/L cutoff, 45 % of frequent and 30 % of occasional smokers were positive 6 h post-smoking.
Discussion
We present the disposition of THC, THCCOOH, CBD, and CBN in OF after controlled smoking of a 6.8 % THC cigarette in 14 chronic, frequent and 10 occasional cannabis smokers. These also are the first OF data after controlled cannabis smoking for the StatSure Saliva Sampler™ device. Only one other study compared chronic and occasional cannabis smokers, but only evaluated THC OF disposition for 8 h [26] , and On admission, all OF specimens from occasional smokers were negative for all analytes, while most OF specimens from chronic frequent smokers were positive, confirming recent cannabis intake based on our previous controlled cannabis administration [16, 17] and sustained abstinence studies [18] . During the 18-h overnight stay, CBD and CBN concentrations decreased until none were positive 1 h prior to smoking. However, OF specimens remained positive for THC and THCCOOH due to residual excretion of previously self-administered smoked cannabis.
Immediately after smoking, high THC, CBD, and CBN concentrations were observed reflecting contamination of the oral mucosa by cannabis smoke. Cannabinoid OF concentrations varied with cannabis plant cannabinoid composition, smoking topography, side stream loss, drug left in the cigarette butt and THC pyrolysis during the burning process [19, 30] . In this study, ad libitum smoking introduced more inter-subject variability, but reflected more naturalistic results than paced smoking protocols, and was especially important for evaluating differences between frequent and occasional cannabis smokers.
Our THC median C max and t max in chronic frequent smokers (Table 2) were respectively lower and later than other studies involving frequent smokers due to the later time of first specimen collection. When we collected OF was collected by expectoration or with the Quantisal™ device after smoking a 6.8 % THC cigarette, C max were obtained in both cases at 0.25 h and were respectively 265-22,370 μg/L and 68-10,284 μg/L [16, 17] . When collected with the Intercept™ device, THC C max was 387-71,747 μg/L 0.08 min after smoking a cannabis cigarette containing 500 μg/kg or about 35 mg THC [26] . These differences are easily explained by times of first OF collection, 0.25 and 0.08 h in the cited studies, and 0.5 h in our study. We chose to delay first collection due to the high number of inadequate volume OF specimens close to the time of smoking noted in our earlier studies [16, 17] . Reduced salivation or dry mouth frequently occurs immediately after cannabis smoking. OF THC concentration drops rapidly after smoking, accounting for C max differences across studies. However, our concentrations at 0.5 h are similar to previous reports: Lee et al. utilized the Quantisal™ device and reported concentrations of 40-6,362 μg/L 0.5 h after smoking a 6.8 % THC cigarette, and after the same dose, expectorated OF concentrations were 311-1,524 μg/L 0.5 h post-smoking [16, 17] . 
For occasional smokers, only one study reported OF THC concentrations between 397 and 6,438 μg/L only 0.08 h (5 min) after smoking a cannabis cigarette containing an equivalent of 500 μg/kg or about 35 mg THC [26] . We observed THC concentrations between 84.5-1,471.3 μg/L at the first sampling (0.5 h). No significant differences (p =0.284) were observed for C max in our study across groups. At our t max (0.5 h), Toennes et al. showed no significant difference in THC concentrations in frequent compared to occasional cannabis smokers due to a more rapid decrease in THC concentrations in frequent smokers from 5 to 15 min [26] . However, in the Toennes study, the Intercept device, utilized for OF collection, has no volume adequacy indicator. It is possible that lowvolume OF collections could have influenced the rate of decline in THC concentrations. Thus, the proposed more rapid decrease in THC concentrations over time in frequent smokers should be verified in specimens of known OF volume. In our study, THC concentrations decreased to medians of 12 (2.5-27.4) and 8.3 (2.7-27.8)μg/L at 6 h for frequent and occasional smokers, respectively. This is in accord with other studies reporting concentrations between 2.1 and 44 μg/L at a similar time [16, 31] . Between 24 and 30 h after smoking, more than 73 % of frequent smokers' OF specimens were still THC-positive; these windows of detection match those reported previously [16, 32, 33] . Toennes et al. [26] showed no significant differences in AUC for 8 h (last collection time) after smoking between 12 frequent and 12 occasional smokers. In our study, we extended monitoring to 30 h with no significant differences in AUC (p =0.539) between chronic and occasional smokers (Table 3) . For our chronic frequent cannabis smokers, CBD and CBN C max concentrations occurred 0.5 h after smoking (Table 3) , in the range previously described by Lee [16, 17] . Observed differences in CBD results could not be due to differences in cigarette CBD content because both the prior and current study employed cannabis cigarettes with identical CBD content. Therefore, observed differences could more likely be explained by inter-individual variations, smoking topographies, OF collection devices (Quantisal in Lee's study and expectorated OF in Milman's), OF volume collected and/ or collection times.
These are the first OF data for CBD and CBN in occasional smokers after controlled smoked cannabinoid administration; thus, no comparison with previous reports is possible. We found no statistically significant differences in CBD and CBN C max (p =0.313 and 0.376 respectively) and AUC (p =0.497 and 0.771) between occasional and frequent smokers. In addition, CBD concentrations in the cannabis cigarette were approximately 3.5 % of THC's (or 0.25 % of cigarette total weight), similar to the relative amount present in the cannabis cigarette. This reflects a similar oral mucosa contamination for CBD and THC. In the 6.8 % THC cigarette, CBN was 3 % of THC's content (or 0.21 % total weight); however in OF specimens, CBN concentration is approximately 8 % of THC's. CBN is a degradation product of THC; therefore, its concentration may be influenced by the conversion of THC to CBN during smoking.
Since THCCOOH is not present in cannabis smoke, OF concentrations must reflect THC metabolism in the liver or oral mucosa. CYP2C9 enzymes, important for formation of 11-OH-THC and THCCOOH, were identified in the liver [34, 35] , and also in human buccal, and tongue cells [36, 37] . For frequent smokers, THCCOOH was present in 97 % of specimens with a last detection time of ≥30 h. THCCOOH peak concentrations occurred between 0.5 and 10.5 h after smoking, with a 2 h median (Table 3) , and were similar to those reported in other studies, <1,118 ng/L after 37 oral THC doses or <764 ng/L after one 6.8 % THC cigarette [14, 16] . In contrast, many OF specimens from occasional smokers were THCCOOH-negative. THCCOOH glucuronide also was reported in OF [38, 39] ; our analytical procedure did not include a hydrolysis step, and thus, results may have been higher following OF hydrolysis. Additional research is required to evaluate THCCOOH-glucuronide concentrations in frequent and occasional cannabis smokers after controlled smoked cannabis administration.
THC and THCCOOH last detection times are difficult to compare across devices in our studies despite smoking of an identical potency cannabis cigarette, because participants were different, monitoring windows were 22 h for Quantisal and expectoration and 30 h for StatSure, and cutoffs varied. Also, windows of detection in chronic frequent smokers generally exceeded the duration of monitoring for THCCOOH in all studies. However, some comparisons are possible. First, the StatSure Saliva Sampler™ produced, within 3 h after smoking, more low OF volume specimens due to dry mouth than the Quantisal™ device (56 vs. 43 %), at identical time points of collection [16] . The StatSure Saliva Sampler™ (1:1v/v) dilutes the sample less than the Quantisal™ device (1:3v/v), increasing sensitivity, and perhaps increasing detection rates and last detection times. At the same cutoffs, THC (0.5 μg/L cutoff) and THCCOOH (15 ng/L cutoff) last detection rates (86 and 93 %, respectively) were higher in OF collected with the StatSure Saliva Sampler™ at 24 h, compared to 67 and 50 % at 22 h, respectively, when OF was collected with the Quantisal™ device. CBD (0.5 μg/L cutoff) and CBN (1 μg/L cutoff) last detection times were similar between studies with 30 and 36 % positive specimens at 6 h and none positive at 22 h. However, the low StatSure OF dilution is a disadvantage as far as total OF/buffer volume available for confirming presumptive positive screening tests, or for multiple chromatographic assays.
Compared to expectorated OF specimens, the StatSure Saliva Sampler™ device had more low-volume specimens [17] . Comparison of THC and THCCOOH last detection times is difficult for the same reasons as described earlier when the StatSure Saliva Sampler™ device was compared to the Quantisal™ device. Overall, there were more positive CBD and CBN specimens when OF was collected by expectoration, due to lack of dilution enhancing sensitivity. However, we recently reported that cannabinoid stability in expectorated OF was poorer than when collected with a stabilizing buffer [40] . In the study by Milman et al., OF specimens were analyzed within 24 h to preclude degradation, thus, these results may not be predictive of other studies with delayed analyses.
Our laboratory recently evaluated different OF cannabinoid cutoff concentrations in frequent smokers during 4-33 days of abstinence and following smoking of a single 6.8 % THC cigarette [16, 18] . These cutoffs were based on CBD, CBN, or THCCOOH concentrations in combination with THC, or on THCCOOH and THC concentrations alone. For frequent smokers, a combination of THC≥1-2 μg/L and CBD or CBN≥1 μg/L provided detection windows shorter than 6 h. These short detection windows also were confirmed for chronic frequent and occasional smokers in the current study (Fig. 2) . Detection windows were dependent on CBD and CBN concentrations, not THC concentrations; thus, THC thresholds of ≥2 or ≥1 μg/L in addition to CBD or CBN≥1 μg/L did not affect last detection times. Using CBN instead of CBD provided longer windows of detection with 45 % of frequent and 30 % of occasional smokers positive 6 h post-smoking. These results showed the importance of measuring CBN and CBD since CBN or CBD cutoff may be appropriate when proof of recent cannabis consumption is needed, for example in DUID or antidoping cases when human performance may be impaired by cannabis intake. However, the absence of CBD and CBN does not preclude recent cannabis smoking, as many OF specimens were negative in frequent and occasional cannabis smokers by 2 h after smoking. Moreover, CBD and CBN content in cannabis cigarettes are variable; thus, windows of detection may vary with cannabinoid cigarette content.
A positive OF CBD and CBN, both present in cannabis smoke, could be due to passive environmental smoke exposure. In the only passive cannabis smoke exposure study measuring CBD and CBN, three of ten subjects exposed for 3 h had up to 2 μg/L CBN in their OF [11] . CBD was not detected at an LOQ of 1 μg/L, possibly due to low CBD content in cannabis cigarettes. THC cutoff concentrations alone (SAMHSA's 2 μg/L or DRUID's 1 μg/L) provided longer detection windows: up to 26 and 30 h for frequent smokers and up to 24 and 26 h for occasional smokers, but cannot exclude acute passive environmental smoke contamination. In addition, THC as the only monitored analyte, would not detect synthetic oral THC intake, and has a shorter detection window in chronic frequent smokers than THCCOOH [14] .
There also are advantages and disadvantages to monitoring only THCCOOH in OF. For advantages, Moore et al. reported the absence of THCCOOH after acute passive environmental exposure when THC and CBN were present [11] , and we reported that OF THCCOOH followed the time course of plasma THCCOOH after controlled oral THC administration [13] [14] [15] . THCCOOH≥20 ng/L provided a higher detection rate (number of specimens positive divided by the total number of specimens collected) in chronic frequent cannabis smokers compared to THC at 1 or 2 μg/L after controlled oral THC administration [12] [13] [14] , after controlled smoked THC [10, 16, 17, 41] , during sustained abstinence [18] and in random cannabis smokers previously positive for THC [42, 43] . However, fewer occasional smokers' OF specimens were THCCOOHpositive. Consequently, a cutoff based on THCCOOH in OF documents cannabis intake, but its absence in occasional cannabis smokers' OF does not exclude cannabis smoking. Quantifying THCCOOH at low nanogram per liter concentration range is challenging and requires development of highly sensitive assays. However, multiple assays meeting this sensitivity requirement are available that employ different analytical systems: two-dimensional GC-MS [27, 44] , GC-MS/MS [42] , LC-MS/MS [45] [46] [47] , and LC-HRMS [48, 49] . These findings confirm the advantages of monitoring multiple cannabinoid markers to improve interpretation of cannabinoid OF results.
Conclusion
These are the first OF cannabinoid data after controlled smoked cannabis administration with OF collection by the Statsure Saliva Sampler™ device. Moreover, THC, THCCOOH, 11-OH-THC, CBD, and CBN OF disposition is compared for the first time after controlled smoked cannabis administration in two different populations, chronic frequent and occasional cannabis smokers. In both groups, maximum THC, CBD, and CBN concentrations occurred just after smoking. No statistically significant differences in the overall cannabinoid time course were observed between frequent and occasional smokers, except for THCCOOH. THCCOOH identified fewer occasional cannabis smokers than THC, but its presence rules out acute passive environmental exposure. Additional research is needed to determine if hydrolysis of THCCOOH-glucuronide would improve detection rates and windows of detection in occasional cannabis smokers. Advantages and disadvantages for setting cannabinoid cutoff concentrations in OF and selecting different OF markers of cannabinoid exposure were described, each providing unique information on an individual's drug use history. Interpretation of cannabinoid OF results is complex due to different routes of drug exposure, potential oral mucosal contamination, and different frequencies and chronicities of exposure.
